JP6320302B2 - 無細胞ｒｎａをプロファイリングおよび定量するための方法 - Google Patents

無細胞ｒｎａをプロファイリングおよび定量するための方法 Download PDF

Info

Publication number
JP6320302B2
JP6320302B2 JP2014554934A JP2014554934A JP6320302B2 JP 6320302 B2 JP6320302 B2 JP 6320302B2 JP 2014554934 A JP2014554934 A JP 2014554934A JP 2014554934 A JP2014554934 A JP 2014554934A JP 6320302 B2 JP6320302 B2 JP 6320302B2
Authority
JP
Japan
Prior art keywords
tissue
rna
cell
specific
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014554934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015511122A (ja
JP2015511122A5 (enExample
Inventor
リアン チェ ウィンストン コー，
リアン チェ ウィンストン コー，
スティーブン アール． クエイク，
スティーブン アール． クエイク，
ヘイ−ムン クリスティーナ ファン，
ヘイ−ムン クリスティーナ ファン，
ウェンイン パン，
ウェンイン パン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of JP2015511122A publication Critical patent/JP2015511122A/ja
Publication of JP2015511122A5 publication Critical patent/JP2015511122A5/ja
Application granted granted Critical
Publication of JP6320302B2 publication Critical patent/JP6320302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00—Pattern recognition
    • G06F18/20—Analysing
    • G06F18/21—Design or setup of recognition systems or techniques; Extraction of features in feature space; Blind source separation
    • G06F18/213—Feature extraction, e.g. by transforming the feature space; Summarisation; Mappings, e.g. subspace methods
    • G06F18/2135—Feature extraction, e.g. by transforming the feature space; Summarisation; Mappings, e.g. subspace methods based on approximation criteria, e.g. principal component analysis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Databases & Information Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Bioethics (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical Kinetics & Catalysis (AREA)
JP2014554934A 2012-01-27 2013-01-28 無細胞ｒｎａをプロファイリングおよび定量するための方法 Active JP6320302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261591642P 2012-01-27 2012-01-27
US61/591,642 2012-01-27
PCT/US2013/023471 WO2013113012A2 (en) 2012-01-27 2013-01-28 Methods for profiling and quantitating cell-free rna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017008768A Division JP2017063799A (ja) 2012-01-27 2017-01-20 無細胞ｒｎａをプロファイリングおよび定量するための方法

Publications (3)

Publication Number Publication Date
JP2015511122A JP2015511122A (ja) 2015-04-16
JP2015511122A5 JP2015511122A5 (enExample) 2016-03-03
JP6320302B2 true JP6320302B2 (ja) 2018-05-09

Family

ID=48874081

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014554934A Active JP6320302B2 (ja) 2012-01-27 2013-01-28 無細胞ｒｎａをプロファイリングおよび定量するための方法
JP2017008768A Pending JP2017063799A (ja) 2012-01-27 2017-01-20 無細胞ｒｎａをプロファイリングおよび定量するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017008768A Pending JP2017063799A (ja) 2012-01-27 2017-01-20 無細胞ｒｎａをプロファイリングおよび定量するための方法

Country Status (9)

Country Link
US (14) US20130252835A1 (enExample)
EP (2) EP2807277A4 (enExample)
JP (2) JP6320302B2 (enExample)
CN (2) CN108359711A (enExample)
AU (1) AU2013211850B8 (enExample)
CA (1) CA2863035C (enExample)
HK (1) HK1211624A1 (enExample)
SG (2) SG11201505515XA (enExample)
WO (1) WO2013113012A2 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3216874A1 (en) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
JP2013509883A (ja) 2009-11-06 2013-03-21 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 臓器移植患者における移植片拒絶反応の非侵襲的診断方法
KR20130113447A (ko) 2010-09-24 2013-10-15 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 고정된 프라이머들을 이용하여 표적 dna의 직접적인 캡쳐, 증폭 및 서열화
US20160289762A1 (en) * 2012-01-27 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
WO2015069900A1 (en) * 2013-11-06 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
HK1211624A1 (en) * 2012-01-27 2016-05-27 The Board Of Trustees Of The University Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free rna
US10689652B2 (en) 2013-10-02 2020-06-23 The Regents Of The University Of California Methods for immortalization of epithelial cells
WO2015069933A1 (en) * 2013-11-06 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Circulating cell-free dna for diagnosis of transplant rejection
KR20240038168A (ko) 2013-11-07 2024-03-22 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 인간 마이크로바이옴 및 그의 성분의 분석을 위한 무세포 핵산
US20170211143A1 (en) 2014-07-25 2017-07-27 University Of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
WO2016077709A1 (en) 2014-11-14 2016-05-19 Liquid Genomics, Inc. Use of circulating cell-free rna for diagnosis and/or monitoring cancer
EP4450636A3 (en) 2015-05-18 2025-01-01 Karius, Inc. Compositions and methods for enriching populations of nucleic acids
US10889861B2 (en) * 2015-06-17 2021-01-12 The Translational Genomics Research Institute Systems and methods for obtaining biological molecules from a sample
US10692797B2 (en) * 2015-06-30 2020-06-23 Laird Technologies, Inc. Thermal interface materials with low secant modulus of elasticity and high thermal conductivity
WO2017062517A1 (en) * 2015-10-06 2017-04-13 The Regents Of The University Of California Non-coding rnas linked to immortality and associated methods and compositions
CN108369612A (zh) * 2015-11-04 2018-08-03 梅塔博隆股份有限公司 自动化样品质量评估
CN116987777A (zh) 2016-03-25 2023-11-03 凯锐思公司 合成核酸掺入物
EP3610034B1 (en) 2017-04-12 2022-06-08 Karius, Inc. Sample preparation methods, systems and compositions
US20200165685A1 (en) * 2017-05-10 2020-05-28 Nantomics, Llc Circulating rna for detection, prediction, and monitoring of cancer
IL296349A (en) * 2017-05-16 2022-11-01 Univ Hong Kong Chinese Integrative single-cell and cell-free plasma rna analysis
CN111566228A (zh) * 2017-10-23 2020-08-21 陈扎克伯格生物中心公司 用于在胎儿孕育中预测胎龄和早产的无创分子钟
TWI833715B (zh) * 2017-10-27 2024-03-01 美商奇諾診療公司 用於超低體積液體生物檢體之裝置、系統及方法
WO2019094363A2 (en) 2017-11-07 2019-05-16 Nanthealth Labs, Inc. Targeted cell free nucleic acid analysis
CA3082601A1 (en) 2018-03-16 2019-09-19 Karius, Inc. Sample series to differentiate target nucleic acids from contaminant nucleic acids
CA3095030A1 (en) 2018-03-30 2019-10-03 Juno Diagnostics, Inc. Deep learning-based methods, devices, and systems for prenatal testing
CN113874525A (zh) * 2018-10-29 2021-12-31 分子听诊器公司 使用无细胞信使rna的骨髓表征
CA3118990A1 (en) 2018-11-21 2020-05-28 Karius, Inc. Direct-to-library methods, systems, and compositions
WO2020132144A1 (en) * 2018-12-18 2020-06-25 Grail, Inc. Methods for detecting disease using analysis of rna
EP4632078A2 (en) * 2019-01-24 2025-10-15 Illumina, Inc. Methods and systems for monitoring organ health and disease
GB2612911B (en) 2019-02-14 2023-11-22 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
WO2020206184A1 (en) * 2019-04-02 2020-10-08 Mission Bio, Inc. Methods, systems, and aparatus for nucleic acid detection
CA3138806A1 (en) 2019-05-22 2020-11-26 Dalia Dhingra Method and apparatus for simultaneous targeted sequencing of dna, rna and protein
US11948684B2 (en) * 2019-06-20 2024-04-02 Latha Chakravarthy Diagnostic process for disease detection using gene expression based multi layer PCA classifier
CN110964800B (zh) * 2019-09-20 2021-10-22 北京航空航天大学 用于预测早产风险的cfRNA标志物
EP4055180A4 (en) * 2019-11-05 2023-12-06 Cofactor Genomics, Inc. METHODS AND SYSTEMS FOR PROCESSING COMPLEX DATA SETS USING ARTIFICIAL INTELLIGENCE AND DECONVOLUTION
AU2020378080A1 (en) * 2019-11-08 2022-06-02 Regeneron Pharmaceuticals, Inc. Accurate and robust information-deconvolution from bulk tissue transcriptomes
JP2023507798A (ja) * 2019-12-20 2023-02-27 ユニヴァーシティー オブ ユタ リサーチ ファウンデーション 健康状態および疾患状態を監視および診断するための方法および組成物
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
CA3172199A1 (en) * 2020-03-18 2021-09-23 Michael Nerenberg Systems and methods of detecting a risk of alzheimer's disease using a circulating-free mrna profiling assay
AU2021324778A1 (en) * 2020-08-13 2023-04-13 Mirvie, Inc. Methods and systems for determining a pregnancy-related state of a subject
WO2024182491A1 (en) * 2023-02-28 2024-09-06 Virginia Commonwealth University Polygenic risk estimator for cervical length change during pregnancy

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629147A (en) 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5432054A (en) 1994-01-31 1995-07-11 Applied Imaging Method for separating rare cells from a population of cells
WO2000040749A2 (en) * 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20080009467A1 (en) 2000-05-01 2008-01-10 Accera, Inc. Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
US6727066B2 (en) 2000-07-28 2004-04-27 Incyte Corporation Genes expressed in treated human C3A liver cell cultures
US6664056B2 (en) * 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
US6977162B2 (en) * 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
WO2003095624A2 (en) 2002-05-10 2003-11-20 Phase-1 Molecular Toxicology, Inc. Liver inflammation predictive genes
US20040086511A1 (en) 2002-07-12 2004-05-06 The Johns Hopkins University Neuronal gene expression patterns
WO2004007674A2 (en) 2002-07-12 2004-01-22 The Johns Hopkins University Neuronal and retinal gene expression patterns
CN101245376A (zh) * 2003-01-17 2008-08-20 香港中文大学 作为妊娠相关病症的诊断标志物的循环mRNA
US20060003342A1 (en) * 2004-01-15 2006-01-05 Bianchi Diana W Fetal RNA in amniotic fluid to determine gene expression in the developing fetus
CA2574706A1 (en) * 2004-07-21 2006-02-23 The Regents Of The University Of California Salivary transcriptome diagnostics
US7713693B1 (en) * 2004-09-01 2010-05-11 University Of Louisiana At Monroe Human cancer cell specific gene transcript
CA2528531A1 (en) * 2005-01-06 2006-07-06 Mount Sinai Hospital Markers of pre-term labor
KR100686816B1 (ko) * 2005-07-22 2007-02-26 삼성에스디아이 주식회사 리튬 이차 전지
TR201910868T4 (tr) * 2006-02-02 2019-08-21 Univ Leland Stanford Junior Dijital analizle invazif olmayan fetal genetik tarama.
EP2302395B1 (en) 2006-06-07 2015-04-15 Health Diagnostic Laboratory, Inc. Markers associated with arteriovascular events and methods of use thereof
US20100145131A1 (en) * 2007-05-01 2010-06-10 Helena Grinberg-Rashi Methods and kits for predicting cancer metastasis
WO2009009457A1 (en) 2007-07-06 2009-01-15 University Of Louisville Research Foundation, Inc. Alzheimer's disease-specific micro-rna microarray and related methods
CN101861399B (zh) * 2007-08-22 2015-11-25 特罗瓦基因公司 使用miRNA检测体内细胞死亡情况的方法
US8298768B2 (en) * 2007-11-29 2012-10-30 Complete Genomics, Inc. Efficient shotgun sequencing methods
JP2011510623A (ja) * 2008-01-27 2011-04-07 ロゼッタ ゲノミックス エルティーディー． 妊娠の合併症を診断するための方法及び組成物
US20110144076A1 (en) * 2008-05-01 2011-06-16 Michelle A Williams Preterm delivery diagnostic assay
WO2009143576A1 (en) 2008-05-27 2009-12-03 Adelaide Research & Innovation Pty Ltd Polymorphisms associated with pregnancy complications
US20110150775A1 (en) * 2008-06-01 2011-06-23 Tufts Medical Center, Inc. Genomic approaches to fetal treatment and diagnosis
US7888030B2 (en) * 2008-08-21 2011-02-15 King's College London Biomarkers
US20110263441A1 (en) 2008-10-15 2011-10-27 Golub Todd R Compositions, kits, and methods for identification, assessment, prevention, and therapy of hepatic disorders
HUE027027T2 (en) 2008-11-13 2016-08-29 Modgene Llc Reduction of amyloid beta load in non-brain tissue
US9051614B2 (en) 2009-09-11 2015-06-09 The Chinese University Of Hong Kong Methods for assessing liver pathologies
WO2011032053A1 (en) * 2009-09-11 2011-03-17 Nugen Technologies, Inc. Compositions and methods for whole transcriptome analysis
EP2510356B1 (en) * 2009-12-08 2018-10-31 Cedars-Sinai Medical Center Diagnostic method to identify women at risk for preterm delivery
JP5755326B2 (ja) * 2010-06-11 2015-07-29 日立化成株式会社 腎機能の特徴を決定する方法
WO2011156734A2 (en) * 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
CA2802305A1 (en) * 2010-07-08 2012-01-12 Pronota N.V. Biomarker for hypertensive disorders of pregnancy
KR20130041961A (ko) * 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
WO2013007708A1 (en) 2011-07-08 2013-01-17 Helmholtz-Zentrum für Infektionsforschung GmbH Medicament for treatment of liver cancer
WO2013022953A2 (en) 2011-08-08 2013-02-14 Eugenia Wang Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof
CA3067612A1 (en) 2011-09-22 2013-03-28 Lineage Biosciences, Inc. Compositions and methods for analyzing heterogeneous samples
SG10201607331WA (en) 2011-09-30 2016-11-29 Somalogic Inc Cardiovascular risk event prediction and uses thereof
US20140304845A1 (en) 2011-10-31 2014-10-09 Merck Sharp & Dohme Corp. Alzheimer's disease signature markers and methods of use
HK1211624A1 (en) 2012-01-27 2016-05-27 The Board Of Trustees Of The University Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free rna
US20160289762A1 (en) * 2012-01-27 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
EP2825665B1 (en) 2012-03-14 2017-09-06 Ruprecht-Karls-Universität Heidelberg Epigenetic signatures as marker for cardiomyopathies and myocardial insufficiencies
US10054599B2 (en) * 2013-03-12 2018-08-21 Agency For Science, Technology And Research (A*Star) Pre-eclampsia biomarkers
BR122019026188B1 (pt) 2013-03-15 2024-01-02 Somalogic Operating Co., Inc Métodos para determinar se um indivíduo com esteatose não alcoólica tem esteato-hepatite não alcoólica e para monitorar um indivíduo com esteatose não alcoólica para o desenvolvimento de nash
JP2018518169A (ja) 2015-06-05 2018-07-12 レグルス セラピューティクス インコーポレイテッド 非アルコール性脂肪肝疾患バイオマーカー
DK3350341T3 (da) 2015-09-14 2021-09-27 Genfit Fremgangsmåder til diagnosticering og evaluering af non-alkoholisk steatohepatitis
EP3426826A4 (en) 2016-03-09 2019-09-04 Molecular Stethoscope, Inc. METHOD AND SYSTEMS FOR DETECTING TISSUE STATES

Also Published As

Publication number Publication date
US20170145508A1 (en) 2017-05-25
US20220290236A1 (en) 2022-09-15
US20130252835A1 (en) 2013-09-26
US20190226029A1 (en) 2019-07-25
US20200362416A1 (en) 2020-11-19
US10240200B2 (en) 2019-03-26
US12365947B2 (en) 2025-07-22
CN104334742A (zh) 2015-02-04
US20210363584A1 (en) 2021-11-25
US20220042098A1 (en) 2022-02-10
WO2013113012A3 (en) 2014-11-06
US10155986B2 (en) 2018-12-18
AU2013211850B2 (en) 2017-03-02
AU2013211850B8 (en) 2017-06-29
HK1211624A1 (en) 2016-05-27
CA2863035C (en) 2023-08-29
US20200370121A1 (en) 2020-11-26
EP2807277A2 (en) 2014-12-03
JP2017063799A (ja) 2017-04-06
JP2015511122A (ja) 2015-04-16
AU2013211850A8 (en) 2017-06-29
US20220213549A1 (en) 2022-07-07
SG10201906331TA (en) 2019-08-27
US20170145507A1 (en) 2017-05-25
CN108359711A (zh) 2018-08-03
US20170145509A1 (en) 2017-05-25
EP2807277A4 (en) 2016-02-17
US20220010381A1 (en) 2022-01-13
US20160017420A1 (en) 2016-01-21
CA2863035A1 (en) 2013-08-01
US10240204B2 (en) 2019-03-26
AU2013211850A1 (en) 2014-09-18
WO2013113012A2 (en) 2013-08-01
US20180357379A1 (en) 2018-12-13
SG11201505515XA (en) 2015-09-29
EP3584327A1 (en) 2019-12-25
US10287632B2 (en) 2019-05-14

Similar Documents

Publication Publication Date Title
JP6320302B2 (ja) 無細胞ｒｎａをプロファイリングおよび定量するための方法
US20230250477A1 (en) Methods and systems for determining a pregnancy-related state of a subject
US20250306012A1 (en) Circulating rna signatures specific to preeclampsia
AU2013240088A1 (en) Rapid aneuploidy detection
US12359256B2 (en) Circulating RNA signatures specific to preeclampsia
WO2015069900A1 (en) Methods for profiliing and quantitating cell-free rna

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150902

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150902

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160114

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161020

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170331

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171102

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180202

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180313

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180403

R150 Certificate of patent or registration of utility model

Ref document number: 6320302

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D04

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250